111 related articles for article (PubMed ID: 9043668)
1. Combinatorial synthesis and biological evaluation of library of small-molecule Ser/Thr-protein phosphatase inhibitors.
Wipf P; Cunningham A; Rice RL; Lazo JS
Bioorg Med Chem; 1997 Jan; 5(1):165-77. PubMed ID: 9043668
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a targeted library of protein phosphatase inhibitors.
Wipf P; Aslan DC; Luci DK; Southwick EC; Lazo JS
Biotechnol Bioeng; 2000; 71(1):58-70. PubMed ID: 10629537
[TBL] [Abstract][Full Text] [Related]
3. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore identification: the case of the ser/thr protein phosphatase inhibitors.
Colby DA; Chamberlin AR
Mini Rev Med Chem; 2006 Jun; 6(6):657-65. PubMed ID: 16787376
[TBL] [Abstract][Full Text] [Related]
5. The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity.
Aggen JB; Humphrey JM; Gauss CM; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem; 1999 Mar; 7(3):543-64. PubMed ID: 10220039
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3.
Woetmann A; Nielsen M; Christensen ST; Brockdorff J; Kaltoft K; Engel AM; Skov S; Brender C; Geisler C; Svejgaard A; Rygaard J; Leick V; Odum N
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10620-5. PubMed ID: 10485875
[TBL] [Abstract][Full Text] [Related]
7. The phosphatase inhibitor okadaic acid stimulates the TSH-induced G1-S phase transition in thyroid cells.
Lazzereschi D; Coppa A; Minicione G; Lavitrano M; Fragomele F; Colletta G
Exp Cell Res; 1997 Aug; 234(2):425-33. PubMed ID: 9260913
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
[TBL] [Abstract][Full Text] [Related]
10. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
11. Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites.
Greif DM; Kou R; Michel T
Biochemistry; 2002 Dec; 41(52):15845-53. PubMed ID: 12501214
[TBL] [Abstract][Full Text] [Related]
12. Cell adhesion regulates Ser/Thr phosphorylation and proteasomal degradation of HEF1.
Zheng M; McKeown-Longo PJ
J Cell Sci; 2006 Jan; 119(Pt 1):96-103. PubMed ID: 16352661
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells.
Liang X; Reed E; Yu JJ
Int J Mol Med; 2006 May; 17(5):703-8. PubMed ID: 16596250
[TBL] [Abstract][Full Text] [Related]
14. Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?
Honkanen RE; Golden T
Curr Med Chem; 2002 Nov; 9(22):2055-75. PubMed ID: 12369870
[TBL] [Abstract][Full Text] [Related]
15. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
Surmeli Z; Gursoy P; Erdogan AP; Bozkurt E; Atmaca H; Uzunoglu S; Sezgin C; Şanlı UA; Uslu R; Karaca B
Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
[TBL] [Abstract][Full Text] [Related]
16. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library.
Vogt A; Rice RL; Settineri CE; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
J Pharmacol Exp Ther; 1998 Nov; 287(2):806-13. PubMed ID: 9808713
[TBL] [Abstract][Full Text] [Related]
17. Regulation of natural killer cell-mediated cytotoxicity by serine/threonine phosphatases: identification of a calyculin A-sensitive serine/threonine kinase.
Bajpai A; Brahmi Z
Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):153-9. PubMed ID: 8947480
[TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibitors of serine/threonine protein phosphatases.
McCluskey A; Sakoff JA
Mini Rev Med Chem; 2001 May; 1(1):43-55. PubMed ID: 12369990
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human neutrophil responses to CD32 cross-linking by serine/threonine phosphatase inhibitors: cross-talk between serine/threonine and tyrosine phosphorylation.
Rollet-Labelle E; Gilbert C; Naccache PH
J Immunol; 2000 Jan; 164(2):1020-8. PubMed ID: 10623852
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
